Leveraging psychiatric and medical genetics to understand comorbid depression and obesity.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28765304.
- Also identified by DOI 10.1192/bjp.bp.116.194662 and PMC identifier 5770192.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Precision medicine in psychiatry is on the rise, and depression and obesity - two highly prevalent, comorbid and well-characterised phenotypes - are optimal targets for the approach. Add the bedrock susceptibility gene, <i>FTO</i>, and Riviera <i>et al</i> have identified a constellation of factors that could enhance clinical treatment of both disorders.
Medical subject headings
- Alpha-Ketoglutarate-Dependent Dioxygenase FTO
- Major Depressive Disorder
- Obesity